Yield10 Bioscience, Inc. (YTENQ)

Market Cap	235.55K
Revenue (ttm)	750.00K
Net Income (ttm)	-12.70M
Shares Out	692.68K
EPS (ttm)	-24.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.340
Previous Close	0.330
Day's Range	0.340 - 0.340
52-Week Range	0.240 - 17.280
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 11, 2025

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 29
• Stock Exchange: OTCMKTS
• Ticker Symbol: YTENQ

Financial Performance

In 2023, Yield10 Bioscience's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.